December 1, 2016
CureDuchenne Aims for a Treatment for the 87%
Read More
September 30, 2016
RARECast: A Controversial Approval for a Duchenne Drug and What Lies Ahead
Read More
August 11, 2016
Early Stage Investment by CureDuchenne Ventures, LLC Enabled Bamboo Therapeutics to Accelerate Development of a Gene Therapy for Duchenne Muscular Dystrophy
Read More
January 5, 2015
Introducing RARECast, the Rare Disease Podcast: Episode 1
Read More
October 3, 2012
Sarepta Therapeutics Clinical Trial Results with Eteplirsen Brings Kids with Duchenne Muscular Dystrophy Closer to Treatment
Read More
X